Faculty

Institution

Unit

Venue

Harold L. Moses

Research Professor

Vanderbilt University

Affiliations

School of Medicine

Department of Pathology, Microbiology, and Immunology

Harold L. Moses is currently serving as a Pathology, Microbiology, And Immunology Research Professor at Vanderbilt University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Harold L. Moses

Vanderbilt University

Research Professor

You can click a keyword to filter the displayed items

cell biology cancer biology cancer research tumor biology oncology medicinal research genetics molecular biology gene expression developmental biology cell signaling cell regulation cancer genetics cancer care cancer genomics mammalian biology molecular cancer membrane biology cancer cells signal transduction cancer treatment vascular biology oncogenes cancer growth regenerative medicine cellular therapy signaling pathways molecular cell biology molecular physiology cellular physiology leukemia stem cell research cell proliferation protein science molecular regulation tumor targeting growth factor cell growth mammary gland biological chemistry embryonic development cellular biology transcription regulation rna biology growth factors experimental medicine angiogenesis breast oncology tissue development cell physiology fibroblast growth factors biomedical research host factors gene regulation skin cancer developmental genetics genitourinary cancers tgf-b signaling cutaneous biology gene function viral oncology growth factor beta clinical medicine protein expression lead ion epidermal growth factor pancreatic ductal adenocarcinoma mouse model growth factor-b myeloid cells stromal fibroblasts growth factor-b signaling transgenic mice mouse embryo cells mammary tumors epithelial cell proliferation tumor suppressor growth inhibitors pathology oncogenic agent

Notable Scholarly Works

Notable Federal Grants

Collaborators

Author Correction: Genotype Tunes Pancreatic Ductal Adenocarcinoma Tissue Tension to Induce Matricellular Fibrosis and Tumor Progression. Nature Medicine (2023)

Hanane LaklaiYekaterina A. MiroshnikovaMichael W. PickupEric A. CollissonGrace E. KimAlex S. BarrettRyan C. HillJohnathon N. LakinsDavid D. SchlaepferJanna K. MouwValerie S. LeBleuNilotpal RoySergey V. NovitskiyJulia S. JohansenValeria PoliRaghu KalluriChristine A. Iacobuzio-DonahueLaura D. WoodMatthias HebrokKirk HansenHarold L. MosesValerie M. Weaver

medicinegenome instabilitytumor biologymatricellular fibrosisoncologycancer researchauthor correctionmatrix biologyhepatologycancer genomicsgeneticsmolecular cancertumor progressionmedical geneticsgenomicsvascular biologygenome biologymedicinal researchgenomic medicinemolecular biologycancer genetics

Data From Gr-1+Cd11B+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung. (2023)

Hannah H. YanMichael PickupYanli PangAgnieszka E. GorskaZhaoyang LiAnna ChytilYipeng GengJerome W. GrayHarold L. MosesLi Yang

lung cancertumor biologycancer immunotherapyimmune responsesimmune protectiononcologyhematological malignanciescancer biologydermatologyadaptive immune systemimmunologypharmacologythoracic oncologycancer riskpremetastatic lungmedicinal researchmyeloid neoplasia

Blocking Vcam-1 Inhibits Pancreatic Tumour Progression and Cancer-Associated Thrombosis/Thromboembolism. Gut (2020)

Makoto SanoRyota TakahashiHideaki IjichiKazunaga IshigakiTomoharu YamadaKoji MiyabayashiGen KimuraSuguru MizunoHiroyuki KatoHiroaki FujiwaraTakuma NakatsukaYasuo TanakaJinsuk KimYohei MasugiYasuyuki MorishitaMariko TanakaTetsuo UshikuYousuke NakaiKeisuke TateishiYukimoto IshiiHiroyuki IsayamaHarold L MosesKazuhiko Koike

gastroenterologyoncologycancer researchgastrointestinal oncologycancer careimmunologypharmacologyviral oncologycancer treatmentthrombosishealth sciences

Inhibition of Transforming Growth Factor-β Signaling in Myeloid Cells Ameliorates Aortic Aneurysmal Formation in Marfan Syndrome. PLoS ONE (2020)

Hironori HaraSonoko MaemuraTakayuki FujiwaraNorifumi TakedaSatoshi IshiiHiroki YagiTakaaki SuzukiMutsuo HaradaHaruhiro TokoTsubasa KanayaHideaki IjichiHarold L. MosesEiki TakimotoHiroyuki MoritaHiroshi AkazawaIssei Komuro

hepatologyhematologyinhibitory activityaortic aneurysmal formationmarfan syndromegene expressioninflammationarterial diseasedermatologyangiogenesisvascular biologyneurologyenzyme inhibitionhealth sciencesgrowth factor-b signalingmyeloid cells

Soluble Vcam-1 Promotes Gemcitabine Resistance via Macrophage Infiltration and Predicts Therapeutic Response in Pancreatic Cancer. Scientific Reports (2020)

Ryota TakahashiHideaki IjichiMakoto SanoKoji MiyabayashiDai MohriJinsuk KimGen KimuraTakuma NakatsukaHiroaki FujiwaraKeisuke YamamotoYotaro KudoYasuo TanakaKeisuke TateishiYousuke NakaiYasuyuki MorishitaKatsura SomaNorihiko TakedaHarold L. MosesHiroyuki IsayamaKazuhiko Koike

cancer immunotherapyhost responsecancer biologyclinical therapeuticstherapeutic responsepharmacologyscientific datacellular therapycancer researchoncologyimmunotherapycancer carecancer treatmentpancreatic cancerimmunologymedicinal researchscientific communicationhealth sciencesmacrophage infiltration

Blocking Cxcls–Cxcr2 Axis in Tumor–Stromal Interactions Contributes to Survival in a Mouse Model of Pancreatic Ductal Adenocarcinoma Through Reduced Cell Invasion/Migration and a Shift of Immune-Inflammatory Microenvironment. Oncogenesis (2019)

Makoto SanoHideaki IjichiRyota TakahashiKoji MiyabayashiHiroaki FujiwaraTomoharu YamadaHiroyuki KatoTakuma NakatsukaYasuo TanakaKeisuke TateishiYasuyuki MorishitaHarold L. MosesHiroyuki IsayamaKazuhiko Koike

cancer immunotherapycancer biologyleukemiacell migrationcell-matrix interactionscarcinogenesistumor biologycellular therapytumor microenvironmentradiation oncologymolecular cancerpancreatic cancerimmunologytumor targetingmouse modelmedicinal researchpancreatic ductal adenocarcinomainflammationdermatologyoncogenesimmune-inflammatory microenvironmenttumor-stromal interactions

Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs. The Oncologist (2019)

Erin P. BaloghAndrew B. BindmanS. Gail EckhardtSusan HalabiR. Donald HarveyIshmael JaiyesimiRebecca MiksadHarold L. MosesSharyl J. NassRichard L. SchilskySteven SunJosephine M. TorrenteKatherine E. Warren

pharmacologyoncology

Bone Marrow–Derived Fibroblasts Are a Functionally Distinct Stromal Cell Population in Breast Cancer. The Journal of Experimental Medicine (2018)

Yael RazNoam CohenOphir ShaniRachel E. BellSergey V. NovitskiyLilach AbramovitzCarmit LevyMichael MilyavskyLeonor Leider-TrejoHarold L. MosesDan GrisaruNeta Erez

hematologytumor biologybone marrow-derived fibroblastsmedicinecancer researchbone researchcancer biologydermatologylaboratory medicinebone marrow transplantationbiomedical researchexperimental biologyexperimental medicineclinical researchhealth sciencesmedicinal researchbreast cancer

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. New England Journal of Medicine (2018)

Robert J. FoxChristopher S. CoffeyRobin ConwitMerit E. CudkowiczTrevis GleasonAndrew GoodmanEric C. KlawiterKazuko MatsudaMichelle McGovernRobert T. NaismithAkshata AshokkumarJanel BarnesDixie EcklundElizabeth KlingnerMaxine KoeppJeffrey D. LongSneha NatarajanBrenda ThornellJon YankeyRobert A. BermelJosef P. DebbinsXuemei HuangPatricia JagodnikMark J. LoweKunio NakamuraSridar NarayananKen E. SakaieBhaskar ThoomukuntlaXiaopeng ZhouStephen KriegerEnrique AlvarezMichelle AppersonKhurram BashirBruce A. CohenPatricia K. CoyleSilvia DelgadoL. Dana DewittAngela FloresBarbara S. GiesserMyla D. GoldmanBurk JubeltNeil LavaSharon G. LynchHarold MosesDaniel OntanedaJai S. PerumalMichael RackePavle RepovicClaire S. RileyChristopher SeversonShlomo ShinnarValerie SuskiBianca Weinstock-GuttmanVijayshree YadavAram Zabeti

medicinecardiologyexperimental medicineimmunologyprogressive multiple sclerosismultiple sclerosisneurologyclinical trials

Functional Kras Mutations and a Potential Role for Pi 3K/ Akt Activation in Wilms Tumors. Molecular Oncology (2017)

Dina PolosukhinaHarold D. LoveHernan CorreaZengliu SuKimberly B. DahlmanWilliam PaoHarold L. MosesCarlos L. ArteagaHarold N. LovvornRoy ZentPeter E. Clark

cancer genomicstumor biologygeneticsgene expressioncancer researchoncologymolecular cancercancer biologycell regulationcancer cellsfunctional genomicsoncogenesoncogenic agentwilms tumorspharmacologymolecular biologycancer genetics

1
2
3
4
5
33
10 / page

Harold L. Moses

Research Professor

Vanderbilt University

Affiliations

School of Medicine

Department of Pathology, Microbiology, and Immunology

Harold L. Moses is currently serving as a Pathology, Microbiology, And Immunology Research Professor at Vanderbilt University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Harold L. Moses

Vanderbilt University

Research Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Author Correction: Genotype Tunes Pancreatic Ductal Adenocarcinoma Tissue Tension to Induce Matricellular Fibrosis and Tumor Progression. Nature Medicine (2023)

Data From Gr-1+Cd11B+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung. (2023)

Hannah H. YanMichael PickupYanli PangAgnieszka E. GorskaZhaoyang LiAnna ChytilYipeng GengJerome W. GrayHarold L. MosesLi Yang

Blocking Vcam-1 Inhibits Pancreatic Tumour Progression and Cancer-Associated Thrombosis/Thromboembolism. Gut (2020)

gastroenterologyoncologycancer researchgastrointestinal oncologycancer careimmunologypharmacologyviral oncologycancer treatmentthrombosishealth sciences

Inhibition of Transforming Growth Factor-β Signaling in Myeloid Cells Ameliorates Aortic Aneurysmal Formation in Marfan Syndrome. PLoS ONE (2020)

Soluble Vcam-1 Promotes Gemcitabine Resistance via Macrophage Infiltration and Predicts Therapeutic Response in Pancreatic Cancer. Scientific Reports (2020)

Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs. The Oncologist (2019)

pharmacologyoncology

Bone Marrow–Derived Fibroblasts Are a Functionally Distinct Stromal Cell Population in Breast Cancer. The Journal of Experimental Medicine (2018)

Yael RazNoam CohenOphir ShaniRachel E. BellSergey V. NovitskiyLilach AbramovitzCarmit LevyMichael MilyavskyLeonor Leider-TrejoHarold L. MosesDan GrisaruNeta Erez

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. New England Journal of Medicine (2018)

medicinecardiologyexperimental medicineimmunologyprogressive multiple sclerosismultiple sclerosisneurologyclinical trials

Functional Kras Mutations and a Potential Role for Pi 3K/ Akt Activation in Wilms Tumors. Molecular Oncology (2017)

Dina PolosukhinaHarold D. LoveHernan CorreaZengliu SuKimberly B. DahlmanWilliam PaoHarold L. MosesCarlos L. ArteagaHarold N. LovvornRoy ZentPeter E. Clark

1
2
3
4
5
33
10 / page

Similar Faculty Members

M. Simon

Institution

University of Pennsylvania

free radical biology

biological microenvironments

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Amato J. Giaccia

Institution

Stanford University

radiation oncology

cancer biology

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Channing Der

Institution

University of North Carolina at Chapel Hill

drug targeting

anti-cancer agent

Dana Borden Lacy

Institution

Vanderbilt University

pathogen

infectious diseases

Daniel G. Tenen

Institution

Harvard University

molecular diagnostics

molecular medicine

Wafik El-Deiry

Institution

Brown University

molecular cancer

pathology

Ralph R. Weichselbaum

Institution

University of Chicago

oncology

radiation oncology

Yu Shyr

Institution

Vanderbilt University

molecular informatics

omics

Similar Faculty Members

M. Simon

Institution

University of Pennsylvania

free radical biology

biological microenvironments

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Amato J. Giaccia

Institution

Stanford University

radiation oncology

cancer biology

Mary Kay Washington, Ph.D., M.D

Institution

Vanderbilt University

immunology

gastrointestinal oncology

Channing Der

Institution

University of North Carolina at Chapel Hill

drug targeting

anti-cancer agent

Dana Borden Lacy

Institution

Vanderbilt University

pathogen

infectious diseases

Daniel G. Tenen

Institution

Harvard University

molecular diagnostics

molecular medicine

Wafik El-Deiry

Institution

Brown University

molecular cancer

pathology

Ralph R. Weichselbaum

Institution

University of Chicago

oncology

radiation oncology

Yu Shyr

Institution

Vanderbilt University

molecular informatics

omics